DOCETAXEL 20 mg/ml (BIOLYSE PHARMA) price in UAE

Overview

Welcome to Dwaey, specifically on DOCETAXEL 20 mg/ml (BIOLYSE PHARMA) Solution for Injection page.
This medicine contains an important and useful components, as it consists of Docetaxel.
DOCETAXEL 20 mg/ml (BIOLYSE PHARMA) is available in the market in concentration 20 mg/ml and in the form of Solution for Injection.

BIOLYSE PHARMA CORPORATION is the producer of DOCETAXEL 20 mg/ml (BIOLYSE PHARMA) and it is imported from CANADA, The most popular alternatives of DOCETAXEL 20 mg/ml (BIOLYSE PHARMA) are listed downward .

Mode Of Action

Docetaxel disrupts the microtubular network in cells that is essential for vital mitotic and interphase cellular functions. It binds to the free tubulin and promotes the assembly of tubulin into stable microtubules while simultaneously inhibiting their disassembly, resulting in inhibition of mitosis.

Indication

Breast cancer
Lung cancer
Prostate cancer
Stomach cancer
Head/neck cancer

Precaution

Lactation. Hepatic impairment. Monitor liver blood function and blood counts regularly. Premedication with oral dexamethsaone at 16 mg daily for 3 days, starting one day before docetaxel treatment is recommended. Lactation: Not known if excreted in breast milk, do not nurse

Side Effects

>50% Alopecia
Anemia
Leukopenia
Neutropenia
Asthenia 10-50% Fever
Infections
Fluid retention
Hypersensitivity
Skin reactions
Diarrhea
Nausea
Vomiting
Sensory neuropathy
Myalgia
Nail changes 1-10% Arthralgia
Thrombocytopenia Potentially Fatal: Neutropenia; fluid retention syndrome; anaemia.

Contra indication

Previous severe hypersensitivity reaction to docetaxel, the solvent or polysorbate 80. Severe neutropenia; pregnancy, severe liver impairment.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.